Select a REGIMEN:
A+D(7+3)(INDUCTION)
A+D+E(7+3+7)(INDUCTION)
HiDAC
IDA-AR 1 (INDUCTION)
IDA-AR 2 (CONSOLIDATION)
MC (INDUCTION)
REGIMEN: A+D(7+3)(INDUCTION)
CYTARABINE [ARA-C] 100 mg/m2 per day x 7 CIV...D1-7
DAUNORUBICIN [DNR] 45 mg/m2 per day IV...D1-3
Caution: Monitor cumulative dose (cardiac toxicity) Note: Repeat
for further induction or consolidation with cytarabine x 5 days
and daunorubicin x 2 days
CYCLE: None
DISEASE: Acute Myelogenous
REGIMEN: A+D+E(7+3+7)(INDUCTION)
CYTARABINE [ARA-C] 100 mg/m2 per day CIV...D1-7
DAUNORUBICIN [DNR] 50 mg/m2 per day IV...D1-3
Caution: Monitor cumulative dose (cardiac toxicity)
ETOPOSIDE [VP-16] 75 mg/m2 per day IV/1 hr...D1-7
CYCLE: Induction
DISEASE: Acute Myelogenous
REGIMEN: HiDAC
CYTARABINE [ARA-C] 1.5 - 3 g/m2 IV/12 h
x 4-6 days
CYCLE: None
DISEASE: Acute Myelogenous
REGIMEN: IDA-AR 1 (INDUCTION)
IDARUBICIN [IDA] 12 mg/m2 per day IV...D1-3
Caution: Monitor cumulative dose (cardiac toxicity)
CYTARABINE [ARA-C] 100 mg/m2 per day x 7 CIV...D1-7
CYCLE: None
DISEASE: Acute Myelogenous
REGIMEN: IDA-AR 2 (CONSOLIDATION)
THIOGUANINE [6-TG] 100 mg/m2 PO q 12h
x 10 doses
CYTARABINE [ARA-C] 100 mg/m2 IV q 12h
x 10 doses
IDARUBICIN [IDA] 15 mg/m2 IV...D1
Caution: Monitor cumulative dose (cardiac toxicity)
CYCLE: 21-28 days x 3 courses
DISEASE: Acute Myelogenous
REGIMEN: MC (INDUCTION)
MITOXANTRONE [DHAD] 12 mg/m2 per day IV...D1-3
Caution: Monitor cumulative dose (cardiac toxicity)
CYTARABINE [ARA-C] 100 mg/m2 per day x 7 CIV...D1-7
CYCLE: Induction